Novo Holdings Repair Impact Fund supports MinervaX EUR 72 million financing to develop vaccine against Group B Streptococcus Read more
Top 20 global biopharma companies report 9.1 per cent QoQ decline in market capitalisation during Q3 2022: GlobalData Read more